Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Szu-Chun Yang

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
JAMA Network Open|June 10, 2025
Biomarker-Specific Survival and Medication Cost for Patients With Non-Small Cell Lung CancerJuanyi Tan, Szu-Chun Yang, Michaela A Dinan, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 7, 2023
Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancerSzu-Chun Yang, Wu-Wei Lai, Tzu-I Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 22, 2021
QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizonWu-Wei Lai, Chia-Hua Chung, Chia-Ni Lin, et al.
BMJ Open|May 13, 2020
Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series studyJason C Hsu, Chen-Fang Wei, Szu-Chun Yang, et al.
Pharmacoeconomics|January 3, 2025
Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung AdenocarcinomaHuang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen, et al.
Plos One|February 16, 2018
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasisWei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, et al.
Pharmacoeconomics|December 17, 2025
Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung AdenocarcinomaHuang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen, et al.
Addiction Science & Clinical Practice|May 21, 2022
Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation programChin-Wei Kuo, Chuan-Yu Chen, Chih-Hsing Wu, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in TaiwanSzu-Chun Yang, Ching-Han Lai, Chin-Wei Kuo, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 26, 2020
Indigenous recurrent disseminated histoplasmosis in TaiwanHung-I Kuo, Xin-Min Liao, Szu-Chun Yang, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
JAMA Network Open|June 10, 2025
Biomarker-Specific Survival and Medication Cost for Patients With Non-Small Cell Lung CancerJuanyi Tan, Szu-Chun Yang, Michaela A Dinan, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 7, 2023
Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancerSzu-Chun Yang, Wu-Wei Lai, Tzu-I Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 22, 2021
QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizonWu-Wei Lai, Chia-Hua Chung, Chia-Ni Lin, et al.
BMJ Open|May 13, 2020
Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series studyJason C Hsu, Chen-Fang Wei, Szu-Chun Yang, et al.
Pharmacoeconomics|January 3, 2025
Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung AdenocarcinomaHuang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen, et al.
Plos One|February 16, 2018
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasisWei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, et al.
Pharmacoeconomics|December 17, 2025
Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung AdenocarcinomaHuang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen, et al.
Addiction Science & Clinical Practice|May 21, 2022
Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation programChin-Wei Kuo, Chuan-Yu Chen, Chih-Hsing Wu, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in TaiwanSzu-Chun Yang, Ching-Han Lai, Chin-Wei Kuo, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 26, 2020
Indigenous recurrent disseminated histoplasmosis in TaiwanHung-I Kuo, Xin-Min Liao, Szu-Chun Yang, et al.
Pageof 6